Exciting news from the innovation front! SyracuseCoE Startup Partner uvcPhyzx, a 2022 Innovation Fund awardee, has made a significant breakthrough in pathogen inactivation. Collaborating with the Syracuse University Department of Biomedical and Chemical Engineering, the team has successfully achieved a two-log reduction of viable gray mold spores in a single-pass test configuration.

This is a major feat considering the notorious difficulty in inactivating gray mold spores, which are tougher to handle than common bacteria and viruses like the Sars-CoV-2 coronavirus.

What sets this achievement apart is the absence of filtration in the process, marking it as one of the first true investigations into using ultraviolet-C (UV-C) light for inactivating aerosolized pathogens. The brains behind this success are Eloise Eyo Parry-Nweye, a Ph.D. student at SU’s College of Engineering and Computer Science, and uvcPhyzx’s CTO Tom Dunbar.

Eloise Eyo Parry-Nweye and Tom Dunbar in the uvcPhyzx lab space

Their collaboration and development of the single-pass test method have opened new doors in the field of pathogen inactivation, demonstrating the potential of UV-C light in combating airborne threats without the need for filtration. This milestone not only highlights the innovative spirit at Syracuse but also promises a brighter future in public health and safety.

Visit the uvcPhyzx website to learn more about their research, or check out SyracuseCoE’s Partner Program and Innovation Fund.